← Leaderboards
Beverly M Emerson
Salk Institute For Biological Studies
$8,328,298
Attributed
$8,328,298
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–15$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$8,328,298 · 7
By mechanism
R01$8,018,749 · 3
P01$279,549 · 2
R13$30,000 · 2
Top collaborators
No co-investigators on record.
Most similar at Salk Institute For Biological Studies
Same institution · by research overlap
- Terrence J Sejnowski$27,798,668
- Xinyu Zhao$18,112,411
- Matthew D. Weitzman$28,955,152
Others in their field
Top investigators on “Chromatin”
- Michael P Snyder · Yale University$98,050,605
- Bing Ren · Ludwig Institute For Cancer Research$76,818,585
- John A Stamatoyannopoulos · Regulome Corporation$56,022,526
- Bradley E Bernstein · Brigham And Women'S Hospital$44,846,223
- Eric J Nestler · Icahn School Of Medicine At Mount Sinai$42,440,927
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$40,714,772
Research focus
ChromatinGene ExpressionGenetic TranscriptionInsightGenomicsTranscription FactorPatternGenesCellsBaseBiochemicalProgramsStagingEpigenetic ProcessProtein Structure FunctionDna Binding ProteinGenetic Enhancer ElementGenetic Promoter ElementDna FootprintingNucleosomesMalignant NeoplasmsComplexGene Expression RegulationGene Induction /Repression
Grant awards (23)
Deregulation of CTCF in Epigenetic Gene Silencing in Human Cancers$395,287
R01 · FY2015 · CA · contact PI
Deregulation of CTCF in Epigenetic Gene Silencing in Human Cancers$383,428
R01 · FY2014 · CA · contact PI
Deregulation of CTCF in Epigenetic Gene Silencing in Human Cancers$371,570
R01 · FY2013 · CA · contact PI
Deregulation of CTCF in Epigenetic Gene Silencing in Human Cancers$395,287
R01 · FY2012 · CA · contact PI
Deregulation of CTCF in Epigenetic Gene Silencing in Human Cancers$395,288
R01 · FY2011 · CA · contact PI
Genomic Mapping of C-G Epigenetic Programs in Hematovascular Progenitor Cells$408,669
R01 · FY2009 · GM · contact PI
Genomic Mapping of C-G Epigenetic Programs in Hematovascular Progenitor Cells$399,181
R01 · FY2008 · GM · contact PI
Specificity of Mammalian SWI/SNF Remodeling Complexes$666,935
R01 · FY2007 · GM · contact PI
Genomic Mapping of C-G Epigenetic Programs in Hematovascular Progenitor Cells$437,147
R01 · FY2007 · GM · contact PI
Specificity of Mammalian SWI/SNF Remodeling Complexes$666,953
R01 · FY2006 · GM · contact PI
Genomic Mapping of C-G Epigenetic Programs in Hematovascular Progenitor Cells$448,472
R01 · FY2006 · GM · contact PI
Specificity of Mammalian SWI/SNF Remodeling Complexes$663,218
R01 · FY2005 · GM
Specificity of Mammalian SWI/SNF Remodeling Complexes$644,010
R01 · FY2004 · GM
REGULATION OF THE HUMAN BETA-GLOBIN LOCUS IN VITRO$611,377
R01 · FY2002 · GM
TRANSCRIPTIONAL REGULATION BY P53 ON GENES$0
P01 · FY2002 · CA
REGULATION OF THE HUMAN BETA-GLOBIN LOCUS IN VITRO$574,274
R01 · FY2001 · GM
Gordon Conference on the Red Cell$20,000
R13 · FY2001 · DK
MECHANISMS OF EUKARYOTIC TRANSCRIPTIONAL REGULATION$10,000
R13 · FY2001 · CA
TRANSCRIPTIONAL REGULATION BY P53 ON GENES$0
P01 · FY2001 · CA
REGULATION OF THE HUMAN BETA-GLOBIN LOCUS IN VITRO$557,653
R01 · FY2000 · GM
TRANSCRIPTIONAL REGULATION OF T-CELL RECEPTOR ALPHA GENE$279,549
P01 · FY2000 · CA
TRANSCRIPTIONAL REGULATION OF T-CELL RECEPTOR ALPHA GENE$0
P01 · FY2000 · CA
TRANSCRIPTIONAL REGULATION OF T-CELL RECEPTOR ALPHA GENE$0
P01 · FY2000 · CA